Streamline your patent due diligence with deep analytics for patents, inventors, and attorneys



Compare patents by technology sector



Deep Analytics



Quickly evaluate patents of interest

► Want to see more? Join for free!

PatentQuant Patent Profile
Generated November 23, 2017

PMI foams with improved mechanical properties, in particular with increased elongation at tear

Patent Number: 9,212,269

Patent Information

Abstract
The invention relates to compounds for producing polymethacrylimide foam materials (PMI foams) with particularly good mechanical properties, in particular with a particularly advantageous elongation at tear. The invention further relates to methods for producing, processing, and using said foam materials. In particular, the invention relates to novel materials, the propensity of which to form tears is clearly reduced in comparison to the prior art. This is tantamount to an elongation at tear that is higher in comparison to the prior art.
Patent Number: 9,212,269
Issue Date: 2015-12-15

Executive Summary

Summary

This patent was granted in ► Log In, which is ► Log In speed.

It has ► Log In claims, which is ► Log In than average for this category.

Its proximity to basic research is ► Log In than others in this category, and it displays ► Log In technology cycle time.

This patent received ► Log In citations from other patents, and references ► Log In other patents, as compared to other patents in this category.

Grant Time

► Log In

Claims

► Log In

► Want to see more? Join for free!

PatentStat Scores in Macromolecular chemistry, polymers
These scores show the percentile ranks for each metric.
For example, a score of 90 means that 90% of similar patents had lower scores.

Patent Grant Time

This patent had ► Log In grant time compared to others in this category.

Patent grant time can be influenced by many factors. Activities within the USPTO that are beyond the control of patent attornies can influence grant time, but short grant times can also indicate well-written patents and dedicated efforts to respond rapidly to USPTO office actions with strong arguments. Shorter grant times are preferable, and the scores for this section are inverse measures — higher scores are better.

Patent Claims

This patent has ► Log In claims compared to others in this category.

The number of claims in a patent is correlated with its strength. Because greater claim counts increase the cost of a patent, more claims can indicate the importance an applicant assigns to a patent. Importantly, some may elect to file claims across multiple patents. A higher score in this metric indicates more claims, relative to others in this category.

Citations From Other Patents

This patent has received ► Log In citations from other patents, than others in this category.

Citations from other patents are an important measure of the significance of a patent. More citations indicate that other technologies build on a patent. Higher scores in this metric are better, and indicate more citations from other patents.

Citations to Other Patents

This patent referenced ► Log In citations to other patents, than others in this category.

A lower number of citations to other patents can be a sign of diminished patent strength. More citations indicate dependence on more other technologies. Higher scores in this category are better, and indicate fewer citations to other patents.

Research and Innovation Indicators
These are percentile ranks — they indicate the percentage of peers with lower scores.

Proximity to Basic Research

► Log In

0%

Proximity to Basic Research

This patent has ► Log In proximity to basic research compared to others in this category.

Proximity to basic research is measured by comparing the number of citations to non-patent literature among a cohort of patents. Because most non-patent citations are primary research papers, a higher count indicates greater proximity to basic research.

► Want to see more? Join for free!

► Want to see more? Join for free!

Information presented on this site is collected from the USPTO and other sources. Errors may have been introduced in the original assembly or analysis of the data.
No warranties are expressed or implied.The content of this site is not a substitute for skilled legal, financial, or other guidance.
Copyright thinkBiotech LLC. All rights reserved.
Privacy policy.
`abc